InvestorsHub Logo
icon url

TheFinalCD

04/27/20 4:49 PM

#132024 RE: Gls3ms #132023

If our own proprietary SARS-CoV-2 Virus-Like Particle (“VLP”) program, IBIO-200, results in an approved vaccine, we estimate that we could make about 500 million doses of high-quality product annually at our Texas facility, depending upon the potency we see in the clinic,” said Tom Isett, Co-Chairman & CEO of iBio.




http://www.globenewswire.com/news-release/2020/04/27/2022802/0/en/iBio-Estimates-500-Million-Dose-Capacity-for-COVID-19-Vaccine-from-its-FastPharming-Facility.html


sorry thats NOT Press Release worthy


thats a what IF




IBIO

#FAKENEWS